At least five Chinese and Hong Kong healthcare companies are working towards IPOs, dual listings or share placements on SGX in the next 12 to 18 months.

Rally in Chinese healthcare signals a structural shift, not a fleeting rebound

Three factors are driving the industry’s market outperformance in Asia

A primary advantage of buyouts is gaining access to the target company’s cash flow as a majority owner, rather than just holding minority equity.

Entering the age of buyouts in healthcare investing

Successful execution of buyout strategies requires a hands-on approach to manage investments effectively

Driven by shifting demographics, rising consumer expectations and an underdeveloped healthcare ecosystem, Asia is primed for rapid healthcare change.
COMMENTARY

In post-pandemic era, South-east Asia primed for rapid healthcare change

While Covid-19 cast a spotlight on the challenges that healthcare systems face throughout the region, there has long been an unmet need...